MarketPulse

regulatory risk

18 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Aquestive Faces Securities Fraud Suit Over Anaphylm FDA Misrepresentation

Aquestive Therapeutics faces securities fraud lawsuit after FDA rejected Anaphylm drug, contradicting management's prior "on track" statements; $AQST stock fell 37%.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Trip.com Faces Securities Lawsuit After 19% Stock Plunge on China Antitrust Probe

Trip.com faces securities lawsuit after 19% stock plunge following China antitrust investigation disclosure. Lead plaintiff deadline set for May 11, 2026.
TCOMsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··James Halley

TRX Gold Surges 42% on Record Production; Single-Asset Risk Looms

TRX Gold shares jump 42% YTD on record Tanzanian production and 40% revenue growth to $57.6M. Expansion plans and cost efficiency offer upside, but single-asset concentration poses risk.
TRXGDXJregulatory riskrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Faces Class Action Over Alleged Monopoly Risk Disclosure Failures

Class action filed against $TCOM alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Trip.com Securities Lawsuit: Investors Face May Deadline in Monopoly Allegations Case

$TCOM faces securities class action over alleged monopolistic practices; investors must act by May 11, 2026 deadline.
TCOMregulatory risksecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Nektar Therapeutics Faces Class Action Over Failed Trial and Alleged Disclosure Failures

Nektar Therapeutics faces class action lawsuit over alleged failure to disclose enrollment protocol violations in failed Phase 2b REZOLVE-AA trial, triggering 8% stock decline.
NKTRclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Hit with Class Action Over Alleged Regulatory Risk Disclosures

Class action lawsuit filed against $TCOM alleging false statements on regulatory risks from monopolistic practices during April 2024-January 2026 period.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Trip.com Faces Securities Class Action Over Antitrust Risk Disclosure

Trip.com faces securities class action over antitrust risk disclosure failures. Stock fell 19.4% after China announced investigation; lead plaintiff deadline set for May 11, 2026.
TCOMsecurities fraudregulatory risk
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Aquestive Therapeutics Hit With Securities Fraud Lawsuit Over FDA Approval Misrepresentations

$AQST plummets 37% after FDA rejects Anaphylm application. Investors sue over alleged misleading statements about approval prospects.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Trip.com Faces Securities Class Action Over Alleged Monopolistic Practice Disclosures

Rosen Law Firm sues Trip.com ($TCOM) over alleged false statements on monopolistic practice risks. Lead plaintiff deadline: May 11, 2026.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Faces Class Action Over Alleged False Statements on Regulatory Risks

Trip.com faces class action alleging false statements about regulatory risks tied to monopolistic practices, covering investors from April 2024 to January 2026.
TCOMsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Motley Fool Youtube

Dutch Bros Brews Through Sugar Scrutiny: Growth Story Survives Regulatory Storm

Dutch Bros faces potential sugar regulation, but analysts believe core growth drivers like store expansion will sustain the company's trajectory.
BROSSBUXregulatory riskstore expansion
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

$TCOM Faces Securities Fraud Lawsuit Over Concealed Antitrust Risks

Trip.com faces securities fraud class action for allegedly understating regulatory risks. Stock fell 17% after China's antitrust investigation was revealed in January 2026.
TCOMsecurities fraudregulatory risk
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Faces Class Action Over Alleged Regulatory Risk Disclosure Failures

Class action lawsuit filed against $TCOM alleging false statements on regulatory risks from monopolistic practices. Lead plaintiff deadline: May 11, 2026.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Trip.com Faces Class Action Over Alleged Antitrust Violations as Stock Plummets 19%

Trip.com faces class action lawsuit over alleged antitrust violations following Chinese regulatory probe; stock drops 19%.
TCOMsecurities fraudclass action lawsuit
Investing.comInvesting.com··Khasay Hashimov

Tesla Faces Critical NHTSA Filing Risk as FSD Investigation Intensifies

Tesla must submit crash data to NHTSA on March 9 regarding Full Self-Driving probe, creating significant near-term volatility risk amid weakening EV sales.
TSLAregulatory riskvaluation
The Motley FoolThe Motley Fool··Lawrence Nga

Robinhood at Inflection Point: 2026 Will Test Path to Sustainable Growth Model

Robinhood faces a 2026 inflection point, needing to prove it can transition from commission-free trading into a diversified financial services provider with sustainable, recurring revenue streams.
HOODfintechregulatory risk
The Motley FoolThe Motley Fool··Josh Kohn-Lindquist

Nu Holdings Shares Slide Despite Robust Earnings Growth

Nu Holdings shares fell 13% despite 45% revenue growth, as investors reassess guidance and worry about U.S. expansion, regulatory risks, and AI integration challenges ahead.
NUearningsNu Holdings